News & Updates

Drug-resistant tuberculosis (DR-TB) is a growing global health issue, and Malaysia is not exempt from this threat. A study appearing in Medical Journal of Malaysia reveals alarming patterns in prevalence, characteristics and treatment outcomes of DR-TB cases in Selangor and Kuala Lumpur.

Research from Queen Mary Hospital in Hong Kong shows that 90 percent of patients with suspected penicillin allergy were delabelled after undergoing Prospective Assessment of Penicillin Allergy (PAPA), and one in six of them received penicillins safely ≥6 months later.

“Zero HIV acquisition” is a milestone that cabotegravir LA as PrEP has realized in the PILLAR real-world trial, along with high persistence observed through 12 months among 201 MSM and transgender men

Cetuximab therapy appears to induce skin complications in patients following central venous port placement, reports a study.

Children with early-onset atopic dermatitis (AD) are at increased odds of developing atopic march conditions compared with those with early-onset AD, reveals a study.

The modified Rapid-O2 oxygen insufflation deviceTM (Rapid-O2) provides sufficient minute volumes (MV) in adults using a 14-gauge (G) inner catheter or 2-mm inner-diameter transtracheal catheter (ID TTC) at 15 L/min, demonstrating its potential for ventilation in cannot intubate, cannot oxygenate (CICO) events.